Pharmacogenetics 1994-02-01

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.

A E Rettie, L C Wienkers, F J Gonzalez, W F Trager, K R Korzekwa

文献索引：Pharmacogenetics 4(1) , 39-42, (1994)

结构式	名称/CAS号	分子式	全部文献
	6-羟基华法林 CAS:17834-02-5	C₁₉H₁₆O₅
	4-羟基甲苯磺丁脲 CAS:5719-85-7	C₁₂H₁₈N₂O₄S
	7-羟基华法林 CAS:17834-03-6	C₁₉H₁₆O₅

Investigation of two-dimensional high performance liquid chr...
2014-10-10
[J. Chromatogr. A. 1363 , 200-6, (2014)]

Hydroxywarfarin metabolites potently inhibit CYP2C9 metaboli...
2010-05-17
[Chem. Res. Toxicol. 23(5) , 939-45, (2010)]

Metabolism of R- and S-warfarin by CYP2C19 into four hydroxy...
2012-09-01
[Drug Metab. Lett. 6(3) , 157-64, (2012)]

Warfarin is an effective modifier of multiple UDP-glucuronos...
2015-01-01
[J. Pharm. Sci. 104(1) , 244-56, (2014)]

Analysis of R- and S-hydroxywarfarin glucuronidation catalyz...
2012-01-01
[J. Pharmacol. Exp. Ther. 340(1) , 46-55, (2012)]